“Rick is an accomplished executive with a proven track record in the medical device industry,” said Jason Spees, Chief Executive Officer at Impulse Dynamics®. “I am thrilled to welcome Rick to the ...
Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) ...
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
Bayer is successfully executing on an ambitious growth strategyFive pivotal approvals worldwide in 2025 underscore a landmark year of strategic executionBayer will drive significant global regulatory ...
Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...
Zacks Investment Research on MSN
Bayer stock jumps on Nubeqa outlook, presents pharma strategy
Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish ...
Rapid weight loss can increase gallstone formation, and hospitalists have reported more cases of biliary colic and ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reports ...
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback